| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SAGE THERAPEUTICS | 259,500 | 13,250,000 | 10.94% | ||
| 2 | LOXO ONCOLOGY INC COM | 360,000 | 11,561,000 | 9.55% | ||
| 3 | AGIOS PHARMACEUTICALS INC | 240,500 | 10,036,000 | 8.29% | ||
| 4 | FOUNDATION MEDICINE INC COM | 546,000 | 9,664,000 | 7.98% | ||
| 5 | Evolent Health, Inc. | 555,000 | 8,214,000 | 6.78% | ||
| 6 | BLUEPRINT MEDICINES CORP COM | 244,500 | 6,858,000 | 5.66% | ||
| 7 | SPARK THERAPEUTICS INC | 128,500 | 6,412,000 | 5.30% | ||
| 8 | GENMARK DIAGNOSTICS INC COM | 510,000 | 6,242,000 | 5.16% | ||
| 9 | BLUEBIRD BIO INCORPORATED | 82,500 | 5,090,000 | 4.20% | ||
| 10 | VOYAGER THERAPEUTICS INC | 385,000 | 4,905,000 | 4.05% | ||
| 11 | GLOBAL BLOOD THERAPEUTICS IN COM | 304,000 | 4,393,000 | 3.63% | ||
| 12 | KITE PHARMA INCORPORATED | 94,000 | 4,215,000 | 3.48% | ||
| 13 | MYOKARDIA INC | 265,000 | 3,432,000 | 2.83% | ||
| 14 | EPIZYME INC COM | 275,000 | 3,328,000 | 2.75% | ||
| 15 | ILLUMINA INC | 25,000 | 3,201,000 | 2.64% | ||
| 16 | ALNYLAM PHARMACEUTICALS INC | 85,000 | 3,182,000 | 2.63% | ||
| 17 | CERNER CORP | 65,000 | 3,079,000 | 2.54% | ||
| 18 | ALLSCRIPTS HEALTHCARE | 280,000 | 2,859,000 | 2.36% | ||
| 19 | AMYRIS INC | 3,425,000 | 2,500,000 | 2.06% | ||
| 20 | SYROS PHARMACEUTICALS INC | 182,141 | 2,215,000 | 1.83% | ||
| 21 | Aevi Genomic Medicine Inc | 375,000 | 1,943,000 | 1.60% | ||
| 22 | CYTOMX THERAPEUTICS INC COM | 127,500 | 1,401,000 | 1.16% | ||
| 23 | ACCELERON PHARMA | 45,000 | 1,148,000 | 0.95% | ||
| 24 | EDITAS MEDICINE INCORPORATED | 65,000 | 1,055,000 | 0.87% | ||
| 25 | GILEAD SCIENCES INC | 12,500 | 895,000 | 0.74% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-17-000699, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
